PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, 2332University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Epidemiology, 2332University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Surgical Oncology, 2332University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/00031348211047205
?:doi
?:hasPublicationType
?:journal
  • The American surgeon
is ?:pmid of
?:pmid
?:pmid
  • 34587799
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34587799>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34587799>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all